Covid-19 in Peru: From supervised walks for children to the first case of Kawasaki-like syndrome

Jaime A. Yáñez, Aldo Alvarez-Risco, Jaime Delgado-Zegarra

Producción científica: Contribución a una revistaArtículo (Contribución a Revista)revisión exhaustiva

44 Citas (Scopus)


To the Editor: Godlee appraises the UK government’s response to covid-19.1 Peru is among the countries with the most covid-19 cases globally,2 reaching 178¿914 cases on 3 June.3 Regardless of this, on 18 May the Peruvian government started allowing supervised walks for people under 14 years old,4 following the Spanish measure implemented on 26 April.5 We have previously expressed our concern for this measure6 because it could lead to a rise in cases in children, who typically exhibit milder symptoms.7 Criticism led to the publication of an epidemiological alert prohibiting supervised walks in most of Peru because of the high risk of contagion.8 By that point, however, thousands of people had already been out with children, as shown in the media.
Idioma originalInglés
Número de artículom2418
PublicaciónThe BMJ
EstadoPublicada - 22 jun. 2020


  • Artículo

Categoría OCDE

  • Políticas de salud, Servicios de salud

Categorías Repositorio Ulima

  • Ciencias / Medicina y Salud

Temas Repositorio Ulima

  • COVID-19
  • Children
  • Mucocutaneous lymph node syndrome
  • Niños
  • Perú
  • Síndrome de los ganglios linfáticos mucocutáneos


Profundice en los temas de investigación de 'Covid-19 in Peru: From supervised walks for children to the first case of Kawasaki-like syndrome'. En conjunto forman una huella única.

Citar esto